Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 105933
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105933
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105933
Table 1 Sequence of primers
| Name | Forward/sense (from 5’ to 3’) | Reverse/antisense (from 5’ to 3’) |
| circRNA_101996 | GAGTGGGAGTGTTGGAAGAAG | TTACTAAAGGCAAACGGTGAA |
| miR-577 | GCGGCGGTAGATAAAATATTGG | ATCCAGTGCAGGGTCCGAGG |
| HMGN5 | GGTTGTCTGCTATGCTTGTG | ACTGCTTCTTGCTTGGTTTC |
| GAPDH | GGAGAGTGTTTCCTCGTCCC | ACTGTGCCGTTGAATTTGCC |
| U6 | GCGCGTCGTGAAGCGTTC | GTGCAGGGTCCGAGGT |
Table 2 The correlation between hsa_circRNA_101996/miR-577/HMGN5 level in gastric cancer tissue and the clinical characteristics of patients, n
| Clinical characteristics | hsa_circRNA_101996 | miR-577 | HMGN5 | ||||||
| Low expression group (≤ median) | High expression group (> median) | P value | Low expression group (≤ median) | High expression group (> median) | P value | Low expression group (≤ median) | High expression group (> median) | P value | |
| Gender | 0.443 | 0.890 | 0.162 | ||||||
| Male | 8 | 10 | 9 | 9 | 7 | 11 | |||
| Female | 13 | 10 | 12 | 11 | 14 | 9 | |||
| Age | 0.890 | 0.262 | 0.443 | ||||||
| > 50 | 12 | 11 | 10 | 13 | 13 | 10 | |||
| ≤ 50 | 9 | 9 | 11 | 7 | 8 | 10 | |||
| Body mass index (kg/m2) | 0.837 | 0.393 | 0.275 | ||||||
| > 24 | 13 | 13 | 12 | 14 | 15 | 11 | |||
| ≤ 24 | 8 | 7 | 9 | 6 | 6 | 9 | |||
| Tumor size (cm) | < 0.001 | 0.043 | 0.003 | ||||||
| > 3 | 5 | 16 | 14 | 7 | 6 | 15 | |||
| ≤ 3 | 16 | 4 | 7 | 13 | 15 | 5 | |||
| TNM stage | 0.654 | 0.086 | 0.412 | ||||||
| 1-2 | 8 | 9 | 6 | 11 | 10 | 7 | |||
| 3-4 | 13 | 11 | 15 | 9 | 11 | 13 | |||
- Citation: Wang XL, Zhang L, Shang Q. Circular RNA hsa_circRNA_101996 modulates gastric cancer cell proliferation and apoptosis through the miR-577/HMGN5 axis. World J Gastrointest Oncol 2025; 17(5): 105933
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/105933.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.105933
